ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy

Giorgio Ciprandi, D. Fenoglio, F. Ferrera, M. De Amici, G. Marseglia

Research output: Contribution to journalArticle

Abstract

Allergic rhinitis (AR) is characterized by a Th2 polarized immune response, and specific immunotherapy modifies this arrangement, restoring a physiologic Th1 profile. Sublingual immunotherapy (SLIT) is widely prescribed. The aim of the study is to evaluate two different methods for assessing IFN-γ, namely ELISPOT and ELISA, before and after a pre-seasonal SLIT course as marker for Th1 response. Thirty-eight AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. Patients' blood samples for assessing IFN-γ serum levels were collected before initiating SLIT (baseline - T0), after 3 months pre-seasonal SLIT course (T1), and three months after completion of SLIT (T2). IFN-γ-specific producing cells, after allergen stimulation, were assessed by cytokine ELISPOT at the same time points. IFN-γ-specific producing cells significantly increased after SLIT both at T1 and T2 (p=0.0002). On the contrary, ELISA assessment did not reveal an increase in IFN-γ serum levels at any time point. In conclusion, these results demonstrate that ELISA assessment of serum IFN-γ is not suitable for identifying an early response.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalEuropean Journal of Inflammation
Volume8
Issue number1
Publication statusPublished - Jan 2010

Fingerprint

Sublingual Immunotherapy
Enzyme-Linked Immunospot Assay
Interferon-gamma
Enzyme-Linked Immunosorbent Assay
Serum
Seasonal Allergic Rhinitis
Immunotherapy
Allergens
Cytokines

Keywords

  • Allergen
  • Allergic rhinitis
  • ELISA
  • ELISPOT
  • IFN-γ
  • Pollens
  • Sublingual immunotherapy
  • Th1 cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy. / Ciprandi, Giorgio; Fenoglio, D.; Ferrera, F.; De Amici, M.; Marseglia, G.

In: European Journal of Inflammation, Vol. 8, No. 1, 01.2010, p. 31-35.

Research output: Contribution to journalArticle

@article{b5bb5fe123e2455299e9c37ea16f47e0,
title = "ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy",
abstract = "Allergic rhinitis (AR) is characterized by a Th2 polarized immune response, and specific immunotherapy modifies this arrangement, restoring a physiologic Th1 profile. Sublingual immunotherapy (SLIT) is widely prescribed. The aim of the study is to evaluate two different methods for assessing IFN-γ, namely ELISPOT and ELISA, before and after a pre-seasonal SLIT course as marker for Th1 response. Thirty-eight AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. Patients' blood samples for assessing IFN-γ serum levels were collected before initiating SLIT (baseline - T0), after 3 months pre-seasonal SLIT course (T1), and three months after completion of SLIT (T2). IFN-γ-specific producing cells, after allergen stimulation, were assessed by cytokine ELISPOT at the same time points. IFN-γ-specific producing cells significantly increased after SLIT both at T1 and T2 (p=0.0002). On the contrary, ELISA assessment did not reveal an increase in IFN-γ serum levels at any time point. In conclusion, these results demonstrate that ELISA assessment of serum IFN-γ is not suitable for identifying an early response.",
keywords = "Allergen, Allergic rhinitis, ELISA, ELISPOT, IFN-γ, Pollens, Sublingual immunotherapy, Th1 cells",
author = "Giorgio Ciprandi and D. Fenoglio and F. Ferrera and {De Amici}, M. and G. Marseglia",
year = "2010",
month = "1",
language = "English",
volume = "8",
pages = "31--35",
journal = "European Journal of Inflammation",
issn = "1721-727X",
publisher = "Biolife",
number = "1",

}

TY - JOUR

T1 - ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy

AU - Ciprandi, Giorgio

AU - Fenoglio, D.

AU - Ferrera, F.

AU - De Amici, M.

AU - Marseglia, G.

PY - 2010/1

Y1 - 2010/1

N2 - Allergic rhinitis (AR) is characterized by a Th2 polarized immune response, and specific immunotherapy modifies this arrangement, restoring a physiologic Th1 profile. Sublingual immunotherapy (SLIT) is widely prescribed. The aim of the study is to evaluate two different methods for assessing IFN-γ, namely ELISPOT and ELISA, before and after a pre-seasonal SLIT course as marker for Th1 response. Thirty-eight AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. Patients' blood samples for assessing IFN-γ serum levels were collected before initiating SLIT (baseline - T0), after 3 months pre-seasonal SLIT course (T1), and three months after completion of SLIT (T2). IFN-γ-specific producing cells, after allergen stimulation, were assessed by cytokine ELISPOT at the same time points. IFN-γ-specific producing cells significantly increased after SLIT both at T1 and T2 (p=0.0002). On the contrary, ELISA assessment did not reveal an increase in IFN-γ serum levels at any time point. In conclusion, these results demonstrate that ELISA assessment of serum IFN-γ is not suitable for identifying an early response.

AB - Allergic rhinitis (AR) is characterized by a Th2 polarized immune response, and specific immunotherapy modifies this arrangement, restoring a physiologic Th1 profile. Sublingual immunotherapy (SLIT) is widely prescribed. The aim of the study is to evaluate two different methods for assessing IFN-γ, namely ELISPOT and ELISA, before and after a pre-seasonal SLIT course as marker for Th1 response. Thirty-eight AR patients with pollen allergy assumed pre-seasonal SLIT for 3 months. Patients' blood samples for assessing IFN-γ serum levels were collected before initiating SLIT (baseline - T0), after 3 months pre-seasonal SLIT course (T1), and three months after completion of SLIT (T2). IFN-γ-specific producing cells, after allergen stimulation, were assessed by cytokine ELISPOT at the same time points. IFN-γ-specific producing cells significantly increased after SLIT both at T1 and T2 (p=0.0002). On the contrary, ELISA assessment did not reveal an increase in IFN-γ serum levels at any time point. In conclusion, these results demonstrate that ELISA assessment of serum IFN-γ is not suitable for identifying an early response.

KW - Allergen

KW - Allergic rhinitis

KW - ELISA

KW - ELISPOT

KW - IFN-γ

KW - Pollens

KW - Sublingual immunotherapy

KW - Th1 cells

UR - http://www.scopus.com/inward/record.url?scp=77952710866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952710866&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77952710866

VL - 8

SP - 31

EP - 35

JO - European Journal of Inflammation

JF - European Journal of Inflammation

SN - 1721-727X

IS - 1

ER -